Pacific Biosciences of California (STU:P09) Ending Cash Position : €52.9 Mil (As of Dec. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Pacific Biosciences of California Ending Cash Position?

Pacific Biosciences of California's Ending Cash Position for the quarter that ended in Dec. 2024 was €52.9 Mil.

Pacific Biosciences of California's quarterly Ending Cash Position declined from Jun. 2024 (€94.6 Mil) to Sep. 2024 (€72.3 Mil) and declined from Sep. 2024 (€72.3 Mil) to Dec. 2024 (€52.9 Mil).

Pacific Biosciences of California's annual Ending Cash Position declined from Dec. 2022 (€306.9 Mil) to Dec. 2023 (€165.0 Mil) and declined from Dec. 2023 (€165.0 Mil) to Dec. 2024 (€52.9 Mil).

Pacific Biosciences of California Ending Cash Position Historical Data

The historical data trend for Pacific Biosciences of California's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pacific Biosciences of California Ending Cash Position Chart

Pacific Biosciences of California Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Ending Cash Position

Get a 7-Day Free Trial

70.65

407.74

306.88

164.98

52.88

Pacific Biosciences of California Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Ending Cash Position	Get a 7-Day Free Trial															164.98	70.51	94.56	72.26	52.88

Pacific Biosciences of California Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Pacific Biosciences of California's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	172.292	+	-119.414
	=	52.9

Pacific Biosciences of California's Ending Cash Position for the quarter that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	74.473	+	-21.595
	=	52.9

Pacific Biosciences of California Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Pacific Biosciences of California's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Pacific Biosciences of California Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Pacific Biosciences of California Inc (STU:P09) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

PACB:USA P09:Germany

Address

1305 O’Brien Drive, Menlo Park, CA, USA, 94025

Website

https://www.pacb.com

Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.

Pacific Biosciences of California Headlines

No Headlines